Skip to main content
. 2025 Jun 23;13:e19644. doi: 10.7717/peerj.19644

Table 1. Clinical variables of PTC patients.

Variables Female Male P value
Total (n = 1,214) 0–34 (n = 228) 35–55 (n = 696) 56– (n = 290) P value Total (n = 436) 0–34 (n = 116) 35–55 (n = 232) 56– (n = 88) P value
Symptoms (n) a 98 (8.07) 9 (3.95) 59 (8.48) 30 (10.34) 0.026 28 (6.42) 6 (5.17) 14 (6.03) 8 (9.09) 0.496 0.157
Course (months) 1.24 0.97 1.15 1.71 0.073 1.1 0.82 1.1 1.47 0.278 0.258
Tumour size (%)
≤1 cm 936 163 553 220 320 78 179 63
>1cm 278 (22.9) 65 (28.51) 143 (20.55) 70 (24.14) 0.039 116 (26.61) 38 (32.76) 53 (22.84) 25 (28.41) 0.13 0.119
Nodule number (%)
Unifocal (n = 1) 724 159 412 153 291 83 157 51
Multifocal (n > 1) 490 (40.36) 69 (30.26) 284 (40.8) 137 (47.24) <0.001 145 (33.26) 33 (28.45) 75 (32.33) 37 (42.05) 0.113 0.009
LNM (%)
No 786 109 462 215 213 39 124 50
Yes 428 (35.26) 119 (52.19) 234 (33.62) 75 (25.86) <0.001 223 (51.15) 77 (66.38) 108 (46.55) 38 (43.18) 0.001 <0.001
LNR (%) 35.8 37.95 34.97 34.99 0.21 48.48 53.92 46.94 41.9 0.041 <0.001

Notes:

LNM, Lymph Node Metastasis; LNR, Lymph node ratio, proportion of positive lymph nodes vs sampled lymph nodes.

a

The number of patients with hoarseness, sore throat, dysphagia, fever, or other symptoms.